Evaluation of MDFA’s education courses for health professionals
Read MoreEvaluation of MDFA’s education courses for health professionals
Read MoreA successful project to train practitioners to screen for diabetic eye disease in Indigenous communities across Australia has been extended.
Read MoreA years-long collaboration between some of Australia’s leading experts in stem cell biology, ophthalmology, and computational biology has produced a genetic roadmap for age-related macular degeneration (AMD) that could be a gamechanger for the discovery of novel treatments.
Read MoreVabysmo is a new treatment for age-related macular degeneration and diabetic macular oedema and is now available on the Pharmaceutical Benefits Scheme (PBS) in Australia
Read MoreMDFA 2022 research update
Read MoreAttend any medical congress and you’ll increasingly hear the terms “artificial intelligence” and “digital diagnosis”
Read MoreOphthalmologists needed for IVI digital support program
Read MoreMDFA is partnering with MyInteract to provide targeted digital information and resources directly to people receiving intravitreal injections (IVI).
Read More